Guardant Health soars 80% in first day of trading
October 04, 2018 at 15:56 PM EDT
Guardant Health CEO Helmy Eltoukhy told CNBC on Thursday the company's liquid biopsy, Guardant360, is a "big game changer" when it comes to the detection of cancer.
